Dr. David Mendelowitz's lab focuses on finding new ways to combat the dangers of opioid overdose, a significant public health crisis. Specifically, they are exploring the potential of oxytocin, a hormone that is already approved for other medical uses, to prevent and treat respiratory depression caused by opioids. The lab aims to test various doses and methods of administering oxytocin in both animal models and clinical trials to assess its effectiveness before, during, and after opioid use.